Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
February 6, 2016
[Methodology in innate immunity to viral HCC]
Kaku Goto, Naoya Kato
Journal of Hepatology
|
January 14, 2017
Histone deacetylase inhibitor for the treatment of hepatocellular carcinoma: Chemoimmunotherapeutic perspective and prospects
Kaku Goto, Naoya Kato
Journal of Gastroenterology
|
October 2, 2014
MICA SNPs and the NKG2D system in virus-induced HCC
Kaku Goto, Naoya Kato
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 10, 2012
[New antivirals against hepatitis C virus]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 14, 2015
[Hepatitis C virus induced hepatocellular carcinoma associated genes]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 22, 2013
[Viral hepatitis]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Oncotarget
|
September 8, 2016
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro
Kaku Goto, Naoya Kato, Raymond T Chung
Oncotarget
|
May 4, 2018
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
Kaku Goto, Jun Arai, Anthony Stephanou, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
February 23, 2026
Refined Modulation of Natural Killer Cells by Transforming Growth Factor-β Isoforms
Kaku Goto, Ryo Amano, Yoshikazu Nakamura, et al.
Current Hepatology Reports
|
August 29, 2022
Targeting Viral cccDNA for Cure of Chronic Hepatitis B
Gaëtan Ligat, Kaku Goto, Eloi Verrier, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
February 6, 2016
[Methodology in innate immunity to viral HCC]
Kaku Goto, Naoya Kato
Journal of Hepatology
|
January 14, 2017
Histone deacetylase inhibitor for the treatment of hepatocellular carcinoma: Chemoimmunotherapeutic perspective and prospects
Kaku Goto, Naoya Kato
Journal of Gastroenterology
|
October 2, 2014
MICA SNPs and the NKG2D system in virus-induced HCC
Kaku Goto, Naoya Kato
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
May 10, 2012
[New antivirals against hepatitis C virus]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 14, 2015
[Hepatitis C virus induced hepatocellular carcinoma associated genes]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 22, 2013
[Viral hepatitis]
Naoya Kato, Ryosuke Muroyama, Kaku Goto
Oncotarget
|
September 8, 2016
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro
Kaku Goto, Naoya Kato, Raymond T Chung
Oncotarget
|
May 4, 2018
Novel therapeutic features of disulfiram against hepatocellular carcinoma cells with inhibitory effects on a disintegrin and metalloproteinase 10
Kaku Goto, Jun Arai, Anthony Stephanou, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms
|
February 23, 2026
Refined Modulation of Natural Killer Cells by Transforming Growth Factor-β Isoforms
Kaku Goto, Ryo Amano, Yoshikazu Nakamura, et al.
Current Hepatology Reports
|
August 29, 2022
Targeting Viral cccDNA for Cure of Chronic Hepatitis B
Gaëtan Ligat, Kaku Goto, Eloi Verrier, et al.
Page
of 5